The binding of 1,25(OH)2D3, 20(OH)D and other vitamin D hydroxy-metabolites to both RORα and RORγ, result in IL17 inhibition (14), thus providing another mechanism distinct from VDR signaling how vitamin D may protect from, or alleviate symptoms of, autoimmune diseases. The gene discussed is RORA; the disease is autoimmune disease.